切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (12) : 1151 -1154. doi: 10.3877/cma.j.issn.1672-6448.2020.12.001

所属专题: 总编推荐 乳腺超声 文献

述评

超声造影诊断乳腺疾病的临床应用现状及展望
董凤林1,()   
  1. 1. 215006 苏州大学附属第一医院超声科
  • 收稿日期:2020-06-28 出版日期:2020-12-01
  • 通信作者: 董凤林

Clinical applications of contrast-enhanced ultrasound in diagnosis of breast diseases: present situation and prospect

Fenglin Dong1()   

  • Received:2020-06-28 Published:2020-12-01
  • Corresponding author: Fenglin Dong
引用本文:

董凤林. 超声造影诊断乳腺疾病的临床应用现状及展望[J]. 中华医学超声杂志(电子版), 2020, 17(12): 1151-1154.

Fenglin Dong. Clinical applications of contrast-enhanced ultrasound in diagnosis of breast diseases: present situation and prospect[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(12): 1151-1154.

1
Youlden DR, Cramb SM, Yip CH, et al. Incidence and mortality of female breast cancer in the Asia-Pacific region [J]. Cancer Biol Med, 2014, 11(2): 101-115.
2
Torre LA, Islami F, Siegel RL, et al. Global cancer in women: burden and trends [J]. Cancer Epidemiology Biomarkers Prev, 2017, 26(4): 444-457.
3
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范 (2019版) [J]. 中国癌症杂志, 2019, 29(8): 609-680.
4
Sood R, Rositch AF, Shakoor D, et al. Ultrasound for breast cancer detection globally: a systematic review and meta-analysis [J]. J Glob Oncol, 2019, 5(8): 1-17.
5
Piscaglia F, Nolsøe C, Dietrich C, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications [J]. Ultraschall Med, 2012, 33(1): 33-59.
6
黄育北, 佟仲生, 陈可欣, 等. 《中国女性乳腺癌筛查指南》解读 (精简版) [J]. 中国肿瘤临床, 2019, 46(9): 432-440.
7
中国医师协会超声医师分会. 中国超声造影临床应用指南 [M]. 1版. 北京: 人民卫生出版社, 2017: 23-24.
8
Wan C, Du J, Fang H, et al. Evaluation of breast lesions by contrast enhanced ultrasound: Qualitative and quantitative analysis [J]. Eur J Radiol, 2012, 81(4): 444-450.
9
Zhao H, Xu R, Ouyang Q, et al. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions [J]. Eur J Radiol, 2010, 73(2): 288-293.
10
Wang YM, Fan W, Zhao S, et al. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound [J]. Eur J Radiol, 2016, 85(1): 48-54.
11
Li J, Guo LP, Yin L, et al. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography ? [J]. Eur J Radiol, 2018, 108(11): 1-6.
12
Leng XL, Huang GF, Ma FC, et al. Regional contrast-enhanced ultrasonography (CEUS) characteristics of breast cancer and correlation with microvessel density (MVD) [J]. Med Sci Monit, 2017, 23(7): 3428-3436.
13
罗俊, 陈吉东, 陈琴, 等. 乳腺良恶性病灶超声造影预测模型在乳腺影像报告与数据系统4类乳腺病灶恶性风险评估中的应用价值[J/CD]. 中华医学超声杂志(电子版), 2016, 13(6): 459-465.
14
Zhao YX, Liu S, Hu YB, et al. Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study [J]. Onco Targets Ther, 2017, 10(2): 1123-1129.
15
Liu G, Zhang MK, He Y, et al. BI-RADS 4 breast lesions: could multi-mode ultrasound be helpful for their diagnosis ? [J]. 2019, 8(3): 258-270.
16
Fujimitsu R, Shimakura M, Urakawa H, et al. Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings [J]. Jpn J Radiol, 2016, 34(7): 508-514.
17
康佳, 吴桐, 张蕾, 等. 不同分子分型乳腺癌的多模态超声特征和临床病理对照研究 [J]. 中华超声影像学杂志, 2020, 29(4): 330-336.
18
后利珠, 董凤林, 郑燕, 等. 超声造影在伴导管扩张的乳腺病变中的应用价值 [J/OL]. 中华医学超声杂志(电子版), 2020, 17(4): 359-362.
19
董凤林, 郑燕, 胡梦裳, 等. 非典型乳腺纤维腺瘤的超声造影表现及病理对照研究 [J]. 中国超声医学杂志, 2018, 34(12): 27-29.
20
邓椀月, 罗俊, 唐丽娜, 等. 乳腺超声造影预测模型在优化乳腺病灶BI-RADS分类中的价值 [J]. 中华超声影像学杂志, 2018, 27(4): 318-322.
21
Luo J, Chen JD, Chen Q, et al. Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesions [J]. World J Radiol, 2016, 8(6): 610-617.
22
黄俊珊, 郏潜新, 欧阳林, 等. 磁共振扩散加权成像联合动态增强扫描在鉴别乳腺癌术后复发与瘢痕的临床研究 [J]. 医学影像学杂志, 2017, 27(12): 2302-2305.
23
Bäz E, Madjar H, Reuss C, et al. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy [J]. Ultrasound Obstet Gynecol, 2000, 15(5): 377-382.
24
Cao X, Xue J, Zhao B. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer [J]. Ultrasound Med Biol, 2012, 38(12): 2065-2071.
25
Kenneth H, Heidi U, Mark L, et al. Ultrasound imaging of breast tumor perfusion and neovascular morphology [J]. Ultrasound Med Biol, 2015, 41(9): 2292-2302.
26
Amioka A, Masumoto N, Gouda N, et al. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy [J]. Jpn J Clin Oncol, 2016, 46(4): 303-309.
27
Lee SC, Grant E, Sheth P, et al. Accuracy of contrast-enhanced ultrasound compared with magnetic resonance imaging in assessing the tumor response after neoadjuvant chemotherapy for breast cancer [J]. J Ultrasound Med, 2017, 36(5): 901-911.
28
Wei Z, Zhan QJ, Masoud B, et al. Clinical application of ultrasound-guided percutaneous microwave ablation for benign breast lesions: a prospective study [J]. Bmc Cancer, 2019, 19(1): 345-355.
No related articles found!
阅读次数
全文


摘要